| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |